Physician profile
Michael Curtis
NPI 1356543714
$21,381.46
in general payments reported to CMS, 2019-2025
15 companies · $14K in 2025
The $14K reported for 2025 was more than what 96% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,080 · 2020: $239 · 2021: $248 · 2022: $1,116 · 2023: $616 · 2024: $2,222 · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $11K · Food and Beverage: $3,261 · Travel and Lodging: $2,084.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,354.00 |
| Food and Beverage | $3,260.94 |
| Travel and Lodging | $2,083.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $14,757.74 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Alloderm, Botox |
| Allergan, INC. | $3,239.38 | 2019-2022 | |
| Rti Surgical, INC | $1,858.73 | 2021-2025 | |
| Stryker Corporation | $655.01 | 2022 | |
| Motiva USA, LLC | $375.00 | 2024-2025 | |
| Derma Sciences, INC. | $129.89 | 2019 | |
| Mentor Worldwide LLC | $122.18 | 2023-2025 | Artoura Breast Tissue Expander, Mentor Memorygel Resterilizable Gel Sizer |
| Vioptix INC | $106.00 | 2019-2024 | T. Ox Tissue Oximeter |
| Ethicon US, LLC | $33.35 | 2024 | Stratafix, Dermabond Prineo, Vistaseal |
| Integra Lifesciences Corporation | $22.92 | 2024 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| W. L. Gore & Associates, INC. | $17.95 | 2019 | |
| Solventum Corporation | $17.33 | 2024 | V.A.C. Granufoam, Prevena |
| Tei Medical INC. | $16.35 | 2019 | |
| Acera Surgical, INC. | $16.22 | 2019 | |
| Tactile Systems Technology INC | $13.41 | 2024 | Flexitouch Plus, Entre Plus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Curtis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.